Aquatic Capital Management LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1803916
CHICAGO, IL
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,800,681
+$960,839 QoQ
Shares Held
10,684
+67.6% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#322
of 768 holders
Holding Since
Jun 2022
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Aquatic Capital Management LLC holds $56,202,914 across 24 Drug Manufacturers - Specialty & Generic names. NBIX ranks #8 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
300,272 | $21,577,545 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
10,212 | $5,533,167 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
122,213 | $5,014,399 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
362,895 | $3,628,950 | |
| 5 | ALKS |
Alkermes plc.
|
66,877 | $3,504,354 | |
| 6 | LQDA |
Liquidia Corp
|
39,623 | $3,159,141 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
41,528 | $2,655,715 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
This page
|
10,684 | $1,800,681 |
All Filings in NBIX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,800,681 | 10,684 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $839,842 | 6,375 | Shares | Sole | 2026-05-15 | |
| 2024-09-30 | $10,243,058 | 88,900 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,414,216 | 24,800 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $60,732 | 600 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $2,878,291 | 27,100 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $253,448 | 2,600 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||